Placeholder Banner

BIO Signs on to Multi-Industry Letter Supporting Critical Infrastructure in Wake of COVID-10 Outbreak

March 25, 2020

In the wake of the COVID-19 outbreak, the Biotechnology Innovation Organization (BIO) joins 111 industry groups across sectors in a letter to federal, state and local lawmakers supporting uniform definitions of "critical infrastructure" as outlined by the Department of Homeland Security and it's Cybersecurity and Infrastructure Security Agency. 

Complete and total adoption of these definitions as a floor across the country will ensure much-needed manufacturers can continue to operate, transport products and have a workforce available. If not adopted widely, curfews that do not consider transportation and workforce needs could quickly become significant barriers to not only supply chains, but also actual supplies. 

To help in the exchange of resources and manufacturing capacity as companies focus on addressing the pandemic, BIO has created the Coronavirus Hub. The hub allows researchers and companies to share their extra capacity and resources with companies that need them. Visit the Coronavirus Hub at hub.bio.org/landing-page/community-home

Download Full Comments Below
Multi Industry Letter Supporting DHS CISA Critical Infrastructure Definitions
Discover More
BIO greatly appreciates efforts from Congress to mitigate the current economic crisis for employers, employees, and all our families. In recent days, we have been asked by several of your colleagues for policy ideas that could assist with…
March 18, 2020 FDA Docket No: FDA-2019-D-4964: FDA Draft Guidance on Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products Dear Sir/Madam: BIO thanks FDA for developing this additional guidance on…
March 15, 2020 Re: Docket No. FDA–2019-D-4752: FDA Draft Guidance, Pediatric Study Plans for Oncology Drugs: Questions and Answers BIO appreciates FDA’s efforts to develop a document that outlines questions and answers pertaining to Pediatric…